Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

SNDX holding history

Syndax Pharmaceuticals Inc in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SNDX overviewAll 13F holders of SNDXFull Q2 2026 holdings

Shares (Q2 2026)
14,564
Value
$318.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of SNDX by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202614,564$318.4K<0.1%−1,858−11.3%ReducedHolders
Q1 202616,422$383.6K<0.1%−2,966−15.3%ReducedHolders
Q4 202519,388$407.3K<0.1%+1,749+9.9%AddedHolders
Q3 202517,639$271.4K<0.1%−3,047−14.7%ReducedHolders
Q2 202520,686$193.7K<0.1%−951−4.4%ReducedHolders
Q1 202521,637$265.8K<0.1%−5,546−20.4%ReducedHolders
Q4 202427,183$359.4K<0.1%+6,627+32.2%AddedHolders
Q3 202420,556$395.7K<0.1%−11,044−34.9%ReducedHolders
Q2 202431,600$648.7K<0.1%+11,488+57.1%AddedHolders
Q1 202420,112$478.7K<0.1%+4,599+29.6%AddedHolders
Q4 202315,513$335.2K<0.1%+2,411+18.4%AddedHolders
Q3 202313,102$190.2K<0.1%+80+0.6%AddedHolders
Q2 202313,022$272.5K<0.1%+1,196+10.1%AddedHolders
Q1 202311,826$249.8K<0.1%−10.0%ReducedHolders
Q4 202211,827$301.0K<0.1%+1,201+11.3%AddedHolders
Q3 202210,626$255.0K<0.1%+433+4.2%AddedHolders
Q2 202210,193$195.0K<0.1%−4,443−30.4%ReducedHolders
Q1 202214,636$254.0K<0.1%−2,149−12.8%ReducedHolders
Q4 202116,785$367.0K<0.1%+634+3.9%AddedHolders
Q3 202116,151$309.0K<0.1%−4,183−20.6%ReducedHolders
Q2 202120,334$349.0K<0.1%+5,478+36.9%AddedHolders
Q1 202114,856$332.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.